Serum IgA/C3 ratio: a useful marker of disease activity in patients with IgA nephropathy

Chauveau D, Droz D (1993) Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol 104:1–5. https://doi.org/10.1159/000422388

Article  PubMed  Google Scholar 

Tomino Y (1999) IgA nephropathy. From molecules to men. Contrib Nephrol 126:III–IX, 1–115

Hiemstra PS, Gorter A, Stuurman ME et al (1987) Activation of the alternative pathway of complement by human serum IgA. Eur J Immunol 17:321–326. https://doi.org/10.1002/eji.1830170304

Article  PubMed  Google Scholar 

Roos A, Rastaldi MP, Calvaresi N et al (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724–1734. https://doi.org/10.1681/ASN.2005090923

Article  PubMed  Google Scholar 

Trascasa ML, Egido J, Sancho J, Hernando L (1980) IgA glomerulonephritis (Berger’s disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 42:247–254

PubMed  PubMed Central  Google Scholar 

Moldoveanu Z, Wyatt RJ, Lee JY et al (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71:1148–1154. https://doi.org/10.1038/sj.ki.5002185

Article  PubMed  Google Scholar 

Tomino Y, Suzuki S, Imai H et al (2000) Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 14:220–223

Article  PubMed  PubMed Central  Google Scholar 

Komatsu H, Fujimoto S, Hara S et al (2004) Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Intern Med 43:1023–1028

Article  PubMed  Google Scholar 

Ishiguro C, Yaguchi Y, Funabiki K et al (2002) Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy. Nephron 91:755–758. https://doi.org/10.1159/000065043

Article  PubMed  Google Scholar 

Zhang J, Wang C, Tang Y et al (2013) Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy. Nephrology 18:125–131. https://doi.org/10.1111/nep.12010

Article  PubMed  Google Scholar 

Hirano K, Matsuzaki K, Yasuda T et al (2019) Association between tonsillectomy and outcomes in patients with immunoglobulin a nephropathy. JAMA Netw Open 2:e194772

Article  PubMed  PubMed Central  Google Scholar 

Suzuki Y, Matsuzaki K, Suzuki H et al (2014) Proposal of remission criteria for IgA nephropathy. Clin Exp Nephrol. https://doi.org/10.1007/s10157-013-0849-x

Article  PubMed  PubMed Central  Google Scholar 

Imai E, Horio M, Nitta K et al (2007) Modification of the Modification of Diet in Renal Disease (MDRD) Study Equation for Japan. Am J Kidney Dis 50:927–937. https://doi.org/10.1053/j.ajkd.2007.09.004

Article  PubMed  Google Scholar 

Maeda A, Gohda T, Funabiki K et al (2003) Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. J Clin Lab Anal 17:73–76. https://doi.org/10.1002/jcla.10071

Article  PubMed  PubMed Central  Google Scholar 

Mizerska-Wasiak M, Małdyk J, Rybi-Szumińska A et al (2015) Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. Pediatr Nephrol 30:1113–1120. https://doi.org/10.1007/s00467-014-3024-z

Article  PubMed  Google Scholar 

Kim SJ, Koo HM, Lim BJ et al (2012) Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One 7:e40495. https://doi.org/10.1371/journal.pone.0040495

Article  PubMed  PubMed Central  Google Scholar 

Zhu L, Zhai Y-L, Wang F-M et al (2015) Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol 26:1195–1204. https://doi.org/10.1681/ASN.2014010096

Article  PubMed  Google Scholar 

Suzuki H, Ohsawa I, Kodama F et al (2013) Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy. J Nephrol 26:708–715. https://doi.org/10.5301/jn.5000278

Article  PubMed  Google Scholar 

Huang H, Sun W, Liang Y et al (2014) CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study. Int Urol Nephrol 46:2361–2369. https://doi.org/10.1007/s11255-014-0851-6

Article  PubMed  Google Scholar 

Masuda Y, Terazawa K, Kawakami S et al (1988) Clinical and immunological study of IgA nephropathy before and after tonsillectomy. Acta Otolaryngol Suppl 454:248–255

Article  PubMed  Google Scholar 

Nishi H, Sugimoto K, Fujita S et al (2012) Effect and therapeutic mechanisms of tonsillectomy for childhood IgA nephropathy. Nephrology 17:658–664. https://doi.org/10.1111/j.1440-1797.2012.01620.x

Article  PubMed  Google Scholar 

Kawaguchi M, Sakai T, Sakamaki A et al (1993) Expanded primary T nodules in the palatine tonsils from patients with IgA nephropathy. Acta Otolaryngol Suppl 508:36–42

Article  PubMed  Google Scholar 

Sato Y, Hotta O, Taguma Y et al (1996) IgA nephropathy with poorly developed lymphoepithelial symbiosis of the palatine tonsils. Nephron 74:301–308. https://doi.org/10.1159/000189325

Article  PubMed  Google Scholar 

Kanamoto Y, Shibata R, Ozono Y, Harada T (1994) Effect of tonsillectomy on peripheral blood T cell surface markers and cytokine production in patients with IgA nephropathy accompanied by chronic tonsillitis. Nihon Jinzo Gakkai Shi 36:1296–1302

PubMed  Google Scholar 

Comments (0)

No login
gif